Relative cell growth analysis showed significant potentiation of T cell mediated killing (both in naïve and CR SCLC cell lines) by FOXM1 inhibitors alone and in combination with cisplatin compared to control or vehicle treated cells (Fig. 6C, supplementary Fig. S14B, S15). The gene discussed is FOXM1; the disease is small cell lung carcinoma.